Incyte Reports 2013 Fourth-Quarter and Year-End Financial Results; Provides 2014 Financial Guidance; Updates Shareholders on Key Clinical Programs

[Business Wire] – Incyte Corporation today reported 2013 fourth-quarter and year-end financial results, including revenue from Jakafi® , which is approved by the U.S. Food & Drug Administration for the treatment of patients with intermediate or high-ris more

View todays social media effects on INCY

View the latest stocks trending across Twitter. Click to view dashboard

See who Incyte is hiring next, click here to view